PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets

NCT00491998 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: V1512
DRUG: V1512
DRUG: V1512 and Entacapone

Sponsor

Vernalis (R&D) Ltd

Collaborators

[object Object]
[object Object]